logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lizhu Pharmaceutical (01513.HK) spent approximately 4.3939 million yuan to repurchase 110,300 A shares on August 15th.

date
15/08/2025
Zhixin Finance APP News, Lijun Pharmaceuticals (01513.HK) announced that on August 15, 2025, it will spend approximately 4.3939 million yuan to repurchase 110,300 shares of A-shares.
Latest
2 m ago
Modern Chinese Medicine Group (01643) announced profits, expecting a mid-term net profit attributable to shareholders of not less than 2 million yuan, a turnaround from a loss in the same period last year.
2 m ago
OLA ELECTRIC Chairman: Will begin delivery of vehicles equipped with self-produced batteries in late September.
2 m ago
China Sky-Bow Holdings (00428.HK) had a comprehensive asset net value of approximately 1.37 Hong Kong dollars per share at the end of July.
3 m ago
Citigroup Group designs debt restructuring deal for Ukraine.
3 m ago
Citigroup Group designed a debt restructuring deal for Ukraine.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.